221 related articles for article (PubMed ID: 9858674)
1. Advantage of the use of human liver S9 in the Ames test.
Hakura A; Suzuki S; Satoh T
Mutat Res; 1999 Jan; 438(1):29-36. PubMed ID: 9858674
[TBL] [Abstract][Full Text] [Related]
2. Salmonella/human S9 mutagenicity test: a collaborative study with 58 compounds.
Hakura A; Shimada H; Nakajima M; Sui H; Kitamoto S; Suzuki S; Satoh T
Mutagenesis; 2005 May; 20(3):217-28. PubMed ID: 15843387
[TBL] [Abstract][Full Text] [Related]
3. Use of human liver S9 in the Ames test: assay of three procarcinogens using human S9 derived from multiple donors.
Hakura A; Suzuki S; Sawada S; Sugihara T; Hori Y; Uchida K; Kerns WD; Sagami F; Motooka S; Satoh T
Regul Toxicol Pharmacol; 2003 Feb; 37(1):20-7. PubMed ID: 12662906
[TBL] [Abstract][Full Text] [Related]
4. Comparison of three different in vitro mutation assays used for the investigation of cytochrome P450-mediated mutagenicity of nitro-polycyclic aromatic hydrocarbons.
Kappers WA; van Och FM; de Groene EM; Horbach GJ
Mutat Res; 2000 Mar; 466(2):143-59. PubMed ID: 10727902
[TBL] [Abstract][Full Text] [Related]
5. Difference in liver homogenates from Donryu, Fischer, Sprague-Dawley and Wistar strains of rat in the drug-metabolizing enzyme assay and the Salmonella/hepatic S9 activation test.
Yoshikawa K; Nohmi T; Miyata R; Ishidate M; Ozawa N; Isobe M; Watabe T; Kada T; Kawachi T
Mutat Res; 1982 Oct; 96(2-3):167-86. PubMed ID: 6755239
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of pyrazole and ethanol induced S9 fraction in bacterial mutagenicity testing.
Burke DA; Wedd DJ; Herriott D; Bayliss MK; Spalding DJ; Wilcox P
Mutagenesis; 1994 Jan; 9(1):23-9. PubMed ID: 8208127
[TBL] [Abstract][Full Text] [Related]
7. [Mutagenicity of mixtures of halogenated aliphatic hydrocarbons and polycyclic aromatic hydrocarbons in the Ames test with TA98 and TA100].
Kevekordes S; Porzig J; Gebel T; Dunkelberg H
Zentralbl Hyg Umweltmed; 1998 Feb; 200(5-6):531-41. PubMed ID: 9531725
[TBL] [Abstract][Full Text] [Related]
8. Effect of cigarette smoke on the mutagenic activation of various carcinogens in hamster.
Mori Y; Iimura K; Furukawa F; Nishikawa A; Takahashi M; Konishi Y
Mutat Res; 1995 Jan; 346(1):1-8. PubMed ID: 7530323
[TBL] [Abstract][Full Text] [Related]
9. [Comparative study on the mutagenic activity of rat liver and bladder S9 by fluctuation test].
Hayashi K; Mashizu N; Haga S; Ubukata N; Sakurai M; Shimizu H
Sangyo Igaku; 1988 Sep; 30(5):385-91. PubMed ID: 3060631
[TBL] [Abstract][Full Text] [Related]
10. The utility of metabolic activation mixtures containing human hepatic post-mitochondrial supernatant (S9) for in vitro genetic toxicity assessment.
Cox JA; Fellows MD; Hashizume T; White PA
Mutagenesis; 2016 Mar; 31(2):117-30. PubMed ID: 26712374
[TBL] [Abstract][Full Text] [Related]
11. Development of high sensitive umu test system: rapid detection of genotoxicity of promutagenic aromatic amines by Salmonella typhimurium strain NM2009 possessing high O-acetyltransferase activity.
Oda Y; Yamazaki H; Watanabe M; Nohmi T; Shimada T
Mutat Res; 1995 Apr; 334(2):145-56. PubMed ID: 7885366
[TBL] [Abstract][Full Text] [Related]
12. The influence of automobile exhausts on mutagenicity of soils: contamination with, fractionation, separation, and preliminary identification of mutagens in the Salmonella/reversion assay and effects of solvent fractions on the sister-chromatid exchanges in human lymphocyte cultures and in the in vivo mouse bone marrow micronucleus assay.
Wesp HF; Tang X; Edenharder R
Mutat Res; 2000 Dec; 472(1-2):1-21. PubMed ID: 11113694
[TBL] [Abstract][Full Text] [Related]
13. Mutagenicity of N-nitrosodiethylamine in the Ames test with S. typhimurium TA1535 is due to volatile metabolites and is not dependent on cytochrome P4502E1 induction.
Westphal GA; Bünger J; Schulz TG; Müller MM; Hallier E
Arch Toxicol; 2000 Dec; 74(10):638-41. PubMed ID: 11201672
[TBL] [Abstract][Full Text] [Related]
14. The spectrum of enzymes involved in activation of 2-aminoanthracene varies with the metabolic system applied.
Veres Z; Török G; Tóth E; Vereczkey L; Jemnitz K
Mutat Res; 2005 Sep; 586(1):18-27. PubMed ID: 16006184
[TBL] [Abstract][Full Text] [Related]
15. S9 induction by the combined treatment with cyclohexanol and albendazole.
Escobar-Garcia D; Camacho-Carranza R; Pérez I; Dorado V; Arriaga-Alba M; Espinosa-Aguirre JJ
Mutagenesis; 2001 Nov; 16(6):523-8. PubMed ID: 11682644
[TBL] [Abstract][Full Text] [Related]
16. Genotoxic bioactivation of constituents of a diesel exhaust particle extract by the human lung.
Iba MM; Caccavale RJ
Environ Mol Mutagen; 2013 Apr; 54(3):158-71. PubMed ID: 23400972
[TBL] [Abstract][Full Text] [Related]
17. Modulation of rat liver cytochrome P450 by protein restriction assessed by biochemical and bacterial mutagenicity methods [corrected].
Cancino-Badías L; Reyes RE; Nosti R; Pérez I; Dorado V; Caballero S; Soria A; Camacho-Carranza R; Escobar D; Espinosa-Aguirre JJ
Mutagenesis; 2003 Jan; 18(1):95-100. PubMed ID: 12473742
[TBL] [Abstract][Full Text] [Related]
18. Activation of mutagens by hepatocytes and liver 9000 X g supernatant from human origin in the Salmonella typhimurium mutagenicity assay. Comparison with rat liver preparations.
Neis JM; Yap SH; van Gemert PJ; Roelofs HM; Bos RP; Henderson PT
Mutat Res; 1986 Feb; 164(1):41-51. PubMed ID: 3512987
[TBL] [Abstract][Full Text] [Related]
19. Comparative activation of 3,3'-dichlorobenzidine and related benzidines to mutagens in the Salmonella typhimurium assay by hepatic S9 and microsomes from rats pretreated with different inducers of cytochrome P-450.
Iba MM
Mutat Res; 1987 Oct; 182(5):231-41. PubMed ID: 3309638
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Escherichia coli DJ4309 expressing human P450 1A2 in mutagenicity testing of complex food mixtures.
Constable A; Varga N; Josephy PD; Guy P; Turesky RJ
Mutat Res; 1999 Jun; 442(2):79-87. PubMed ID: 10393276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
